You can buy or sell EGRX and other stocks, options, ETFs, and crypto commission-free!
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. Read More The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Woodcliff Lake, New Jersey
52 Week High
52 Week Low
Recent Performance: Eagle Pharmaceuticals (NASDAQ: EGRX)
Eagle Pharmaceuticals trades as part of the healthcare sector and trades as part of the drug manufacturers industry. The company CEO is Scott L. Tarriff. Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Previous Intraday Trading Performance: The EGRX stock showed a previous change of -1.97% with an open at 48.87 and a close of 47.89. It reached an intraday high of 49.36...
Yahoo FinanceFeb 21
Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Eagle Pharmaceuticals (EGRX) reports results for the quarter ended December 2018. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
Expected May 9, Pre-Market